Egis revenue going high
Shareholders of Hungarian drug maker Egis, majority-owned by France’s Servier, approved payment of a HUF 120-per-share dividend on after-tax profit from the business year ended September 30 at an annual general meeting on Wednesday.
Egis has paid a HUF 120-per-share dividend for years. The dividend fund comes to HUF 934m. The remaining HUF 15.7bn of after-tax profit will be place into profit reserves.CFO Csaba Poroszlai said 95% of the company’s consolidated revenue of HUF 128.9bn was generated directly by the parent company, while export accounted for 73% of the revenue. Egis introduced eight new products during the business year, Mr Poroszlai added.
Related news
Related news
Location becomes a competitive factor in e-commerce
As digitalisation and consumer expectations evolve rapidly, logistics and warehousing…
Read more >Gyermelyi is strengthening in exports – adapting to the challenges
Based on the 2024 financial report of Gyermelyi Zrt., it…
Read more >Voluntary Water Donor Program Launches in Budapest
10 million Trees, the Budapest Municipality, the Főkert and the…
Read more >